Renalase Assessment With Regard to Kidney Function,Lipid Disturbances,and Endothelial Dysfunction Parameters in Stable Renal Transplant Recipients

Abstract

Background:

Renal transplant dysfunction has been shown to be independent predictor for premature cardiovascular disease and mortality. Renalase, a flavoprotein secreted by several tissues, including the kidney, has been found to regulate sympathetic tone and blood pressure. The purpose of this secondary analysis was to explore relationships among parameters of endothelial dysfunction, lipids, glomerular filtration rate, and renalase in 2 groups: renal transplant patients with controlled hypertension and healthy volunteers.

Methods:

In the parent study, 73 renal transplant recipients and 32 age- and gender-matched controls were enrolled. A fasting sample for endothelial, lipid, and renalase values, along with other clinical parameters, was obtained.

Results:

We found statistically significant inverse correlation between renalase and estimated glomerular filtration rate (r = −0.552, P < .001), positive correlation between renalase and creatinine (r = 0.364, P = .003), total cholesterol (r = 0.578, P < .001), low-density lipoprotein cholesterol (r = 0.261, P = .046), and non-high-density lipoprotein cholesterol (r = 0.327, P = .01). Renalase inversely correlated with hemoglobin (r = −0.232, P = .032) and positively with white blood cells (r = 0.233, P = .032). There was a significant difference in plasma renalase with regard to chronic kidney disease stages (F = 13.346, P < .001) but did not correlate with C-reactive protein. Renalase did not correlate with any of parameters of endothelial dysfunction, C-reactive protein, neither with some demographic data (gender, age, time or type of transplantation, risk factors). There were no differences in renalase concentration with regard to antihypertensive therapy.

Conclusion:

Renalase strongly and inversely correlated with kidney function, positively with creatinine and lipid disturbances. Due to that it is very likely that renalase levels are determined mostly by renal function.

Keywords

ADMA kidney transplantation renalase renal dysfunction

Get full access to this article

View all access options for this article.

References

Lam

Kim

Knoll

. The risk of cardiovascular disease is not increasing over time despite aging and higher comorbidity burden of kidney transplant recipients. Transplantation. 2017;101(3):588–596. doi:10.1097/TP.0000000000001155.

Pita-Fernández

Pertega-Díaz

Valdes-Cañedo

. Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: study protocol. BMC Cardiovasc Disord. 2011;11:2. doi:10.1186/1471-2261-11-2.

Tripepi

Mattace Raso

Sijbrands

. Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients. Clin J Am Soc Nephrol. 2011;6(7):1714–1721. doi:10.2215/CJN.11291210.

Soveri

Holdaas

Jardine

Gimpelewicz

Staffler

Fellstrom

. Renal transplant dysfunction—importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality. Nephrol Dial Transplant. 2006;21(8):2282–2289.

Roodnat

Hilbrands

Hené

. 15-year follow-up of a multicenter, randomized, calcineurin inhibitor withdrawal study in kidney transplantation. Transplantation. 2014;98(1):47–53. doi:10.1097/01.TP.0000442774.46133.71

Ewen

Ukena

Linz

Schmieder

Böhm

Mahfoud

. The sympathetic nervous system in chronic kidney disease. Curr Hypertens Rep. 2013;15(4):370–376. doi:10.1007/s11906-013-0365-0.

Böhm

Linz

Urban

Mahfoud

Ukena

. Renal sympathetic denervation: applications in hypertension and beyond. Nat Rev Cardiol. 2013;10(8):465–476. doi:10.1038/nrcardio.2013.89.

Desir

Wang

Peixoto

. Human renalase: a review of its biology, function, and implications for hypertension. J Am Soc Hypertens. 2012;6(6):417–426. doi:10.1016/j.jash.2012.09.002.

Desir

Peixoto

. Renalase in hypertension and kidney disease. Nephrol Dial Transplant. 2014;29(1):22–28. doi:10.1093/ndt/gft083.

10.

Schwedhelm

Böger

. The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol. 2011;7(5):275–285. doi:10.1038/nrneph.2011.31.

11.

Stojanovic

Cvetkovic

Stojanovic

. Crosstalk of inflammatory mediators and lipid parameters as early markers of renal dysfunction in stable renal transplant recipients with regard to immunosuppression. Ann Transplant. 2013;18:414–423.

12.

National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 suppl 1):S1–S266.

13.

Paroni

Fermo

Fiorina

Cighetti

. Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects. Amino Acids. 2005;28(4):389–394.

14.

Fellstrom

Jardine

Soveri

. Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation. Am J Transplant. 2005;5(8):1986–1991.

15.

Stoumpos

Jardine

Mark

. Cardiovascular morbidity and mortality after kidney transplantation. Transpl Int. 2015;28(1):10–21. doi:10.1111/tri.12413.

16.

Velazquez

. Renalase deficiency aggravates ischemic myocardial damage. Kidney Int. 2011;79(8):853–860. doi:10.1038/ki.2010.488.

17.

Przybylowski

Malyszko

Kozlowska

Malyszko

Koc-Zorawska

Mysliwiec

. Serum renalase depends on kidney function but not on blood pressure in heart transplant recipients. Transplant Proc. 2011;43(10):3888–3891. doi:10.1016/j.transproceed.2011.08.075.

18.

Zbroch

Małyszko

Koc-Żorawska

Myśliwiec

. Renalase, kidney function, and markers of endothelial dysfunction in renal transplant recipients. Pol Arch Med Wewn. 2012;122(1-2):40–44.

19.

Schlaich

. Sympathetic activation in chronic kidney disease: out of the shadow. Hypertension. 2011;57(4):683–685. doi:10.1161/HYPERTENSIONAHA.110.167189.

20.

Desir

Tang

Wang

. Renalase lowers ambulatory blood pressure by metabolizing circulating adrenaline. J Am Heart Assoc. 2012;1(4):e002634. doi:10.1161/JAHA.112.002634.

21.

Malyszko

Zbroch

Malyszko

Koc-Zorawska

Mysliwiec

. Renalase, a novel regulator of blood pressure, is predicted by kidney function in renal transplant recipients. Transplant Proc. 2011;43:(8):3004–3007. doi:10.1016/j.transproceed.2011.08.032.

22.

Zbroch

Malyszko

Koc-Zorawska

Mysliwiec

. Renalase, a novel enzyme involved in blood pressure regulation, is related to kidney function but not to blood pressure in hemodialysis patients. Kidney Blood Press Res. 2012;35(6):395–399. doi:10.1159/000338178.

23.

Stojanovic

Cvetkovic

Stojanovic

Bojanic

Stefanovic

Stojanovic

. The assessment of renalase: searching for the best predictor of early renal dysfunction by multivariate modeling in stable renal transplant recipients. Ann Transplant. 2015;20:186–192. doi:10.12659/AOT.892632.

24.

Grassi

Seravalle

Ghiadoni

. Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(11):2620–2627. doi:10.2215/CJN.06970711.